Exact Mass: 777.3623372
Exact Mass Matches: 777.3623372
Found 27 metabolites which its exact mass value is equals to given mass value 777.3623372,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide
5-{6-[(2,2-diphenylethyl)amino]-2-[(2-{n-[1-(pyridin-2-yl)piperidin-4-yl]-(C-hydroxycarbonimidoyl)amino}ethyl)carbamoyl]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxyoxolane-2-carboximidate
C40H47N11O6 (777.3710602000001)
22-adenosine monophosphoric ester of 2-deoxyecdysone|22-adenosinemonophosphoric ester of 2-deoxyecdysone
22-adenosine monophosphoric ester of 2-deoxyecdysone|22-adenosinemonophosphoric ester of 2-deoxyecdysone
(15Xi)-15-acetoxy-O3-(N-isobutyryl-N-methyl-L-alanyl)-maytansinol|(2Xi,3E,5E,7R,84S)-2-acetoxy-14-chloro-10t,11c-epoxy-84-hydroxy-12c-(N-isobutyryl-N-methyl-L-alanyloxy)-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione|Colubrinol acetate|Colubrinol-acetat|O-acetyl-colubrinol
(15Xi)-15-acetoxy-O3-(N-isobutyryl-N-methyl-L-alanyl)-maytansinol|(2Xi,3E,5E,7R,84S)-2-acetoxy-14-chloro-10t,11c-epoxy-84-hydroxy-12c-(N-isobutyryl-N-methyl-L-alanyloxy)-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione|Colubrinol acetate|Colubrinol-acetat|O-acetyl-colubrinol
Miliiamine C 20-Ac, N-de-Me - Ingenol diterpenoid
Miliiamine C 20-Ac, N-de-Me - Ingenol diterpenoid
C44H47N3O10 (777.3261282000001)
Miliiamine C, 20-Ac, N-de-Me - ingenol diterpenoid
Miliiamine C, 20-Ac, N-de-Me - ingenol diterpenoid
C44H47N3O10 (777.3261282000001)
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]arbonyl]-N-2-pyridin
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]arbonyl]-N-2-pyridin
6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide
6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide
C40H47N11O6 (777.3710602000001)
Miliiamine C 20-Ac, N-de-Me-Ingenol diterpenoid
Miliiamine C 20-Ac, N-de-Me-Ingenol diterpenoid
C44H47N3O10 (777.3261282000001)
6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide
5-{6-[(2,2-diphenylethyl)amino]-2-[(2-{n-[1-(pyridin-2-yl)piperidin-4-yl]-(C-hydroxycarbonimidoyl)amino}ethyl)carbamoyl]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxyoxolane-2-carboximidate
C40H47N11O6 (777.3710602000001)
CYM2503
CYM2503
CYM2503 is a putative GalR2-positive allosteric modulator. CYM2503 increases the latency to first electrographic seizure and decreases the total time in seizure. CYM2503 also attenuates electroshock-induced seizures in mice. Galanin receptors type 1 (GalR1) and/or type 2 (GalR2) represent unique pharmacological targets for the research of seizures and epilepsy[1].
(4s,10s,13s,16s,19s,22r)-10-[(2s)-butan-2-yl]-3,12,15,18,21,24-hexahydroxy-16-[(1r)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-13-methyl-22-(sec-butyl)-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
(4s,10s,13s,16s,19s,22r)-10-[(2s)-butan-2-yl]-3,12,15,18,21,24-hexahydroxy-16-[(1r)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-13-methyl-22-(sec-butyl)-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
n-{2-[({7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl}oxy)carbonyl]phenyl}-3-hydroxy-2-({hydroxy[2-(methylamino)phenyl]methylidene}amino)benzenecarboximidic acid
n-{2-[({7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl}oxy)carbonyl]phenyl}-3-hydroxy-2-({hydroxy[2-(methylamino)phenyl]methylidene}amino)benzenecarboximidic acid
C44H47N3O10 (777.3261282000001)
11-(4-hydroxyphenyl)-n-[5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-3,12-diisopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]undeca-2,4,6,8,10-pentaenimidic acid
11-(4-hydroxyphenyl)-n-[5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-3,12-diisopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]undeca-2,4,6,8,10-pentaenimidic acid
(4s,10s,13s,16s,19s,22s)-10,22-bis[(2s)-butan-2-yl]-3,12,15,18,21,24-hexahydroxy-16-[(1r)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-13-methyl-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
(4s,10s,13s,16s,19s,22s)-10,22-bis[(2s)-butan-2-yl]-3,12,15,18,21,24-hexahydroxy-16-[(1r)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-13-methyl-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
(2-{3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-6-methylheptan-3-yl)oxy([5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy)phosphinic acid
(2-{3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-6-methylheptan-3-yl)oxy([5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy)phosphinic acid
n-[2-({[(1s,4s,5s,6r,9s,10r,12r,14r)-7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl]oxy}carbonyl)phenyl]-3-hydroxy-2-({hydroxy[2-(methylamino)phenyl]methylidene}amino)benzenecarboximidic acid
n-[2-({[(1s,4s,5s,6r,9s,10r,12r,14r)-7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl]oxy}carbonyl)phenyl]-3-hydroxy-2-({hydroxy[2-(methylamino)phenyl]methylidene}amino)benzenecarboximidic acid
C44H47N3O10 (777.3261282000001)
[(2s,3r)-2-[(1r,3as,5ar,7s,9ar,9br,11ar)-3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylheptan-3-yl]oxy([(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy)phosphinic acid
[(2s,3r)-2-[(1r,3as,5ar,7s,9ar,9br,11ar)-3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylheptan-3-yl]oxy([(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy)phosphinic acid
(1s,2r,3s,5s,6s,15r,16e,18e,20r,21s)-15-(acetyloxy)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2r)-2-(n,2-dimethylpropanamido)propanoate
(1s,2r,3s,5s,6s,15r,16e,18e,20r,21s)-15-(acetyloxy)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2r)-2-(n,2-dimethylpropanamido)propanoate
3,12,15,18,21,24-hexahydroxy-16-(1-hydroxyethyl)-19-[(4-hydroxyphenyl)methyl]-13-methyl-10,22-bis(sec-butyl)-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
3,12,15,18,21,24-hexahydroxy-16-(1-hydroxyethyl)-19-[(4-hydroxyphenyl)methyl]-13-methyl-10,22-bis(sec-butyl)-2,8,11,14,17,20,23-heptaazatricyclo[23.4.0.0⁴,⁸]nonacosa-1(29),2,11,14,17,20,23,25,27-nonaen-9-one
(2e,4e,6e,8e,10e)-11-(4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-3,12-diisopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]undeca-2,4,6,8,10-pentaenimidic acid
(2e,4e,6e,8e,10e)-11-(4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-3,12-diisopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]undeca-2,4,6,8,10-pentaenimidic acid
15-(acetyloxy)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl 2-(n,2-dimethylpropanamido)propanoate
15-(acetyloxy)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl 2-(n,2-dimethylpropanamido)propanoate